More Genetic Variations for Schizophrenia Discovered

In the first study to explore the entire human genome for variations that may influence the development of schizophrenia, researchers have discovered two new sites of genetic variation that are closely associated with the disease.  “By implicating two previously unknown sites, this study triples the number of genomic areas definitely linked to schizophrenia,” said NIMH Director R Thomas Insel, M.D. Read more

Could Schizophrenia Be Entirely Genetic?

The latest gene-scanning technology may have shed some much-desired light on a potential cause for schizophrenia, a mental disorder characterized by delusions and scrambled thought processes. The disease is believed to affect 1% of the population. Read more

Common Schizophrenia Drug on Trial

The pharmaceutical giant, Eli Lilly, is being sued by the state of Alaska over allegedly covering up the potential risks of Zyprexa (olanzapine). Attorneys for the state argue that the company knew that the drug, approved for the treatment of Schizophrenia and acute manic and mixed episodes of Bipolar Disorder, may cause diabetes in patients taking it. Read more